[Clinical experience with a new spasmolytic (avacan)].
D002317:Cardiovascular Agents; D005998:Glycine / Q000031:analogs & derivatives; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D010276:Parasympatholytics
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central; D010276:Parasympatholytics; C004644:camylofine; D005998:Glycine
MUSCLE RELAXANTS/therapeutic use
Klinische Erfahrungen mit einem neuartigen Spasmolytikum (Avacan).